Signal Research suggests AI can cut drug development time by up to 40 percent

Summary

The report cites recent research findings on the effect of AI in pharmaceutical development. According to those findings, using AI can shorten drug development time by up to 40 percent. The same research suggests that AI can reduce clinical trial failure rates by as much as 70 percent. The report presents these figures as evidence that AI is becoming a core tool for turning biomedical big data into usable knowledge. It uses them to support the view that AI-based drug development is moving into the mainstream of the industry.